Page last updated: 2024-08-18

phenformin and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

phenformin has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atrih, A; Cantrell, DA; Dandapani, M; Foretz, M; Grzes, KM; Hardie, DG; Lamont, DJ; Russell, FM; Vara-Ciruelos, D; Viollet, B1

Other Studies

1 other study(ies) available for phenformin and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
    Cell reports, 2019, 04-16, Volume: 27, Issue:3

    Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Disease Models, Animal; Disease-Free Survival; Female; Glycolysis; Hypoglycemic Agents; Male; Mechanistic Target of Rapamycin Complex 1; Metformin; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenformin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; PTEN Phosphohydrolase; Signal Transduction; Sirolimus

2019